Semaglutide in Patients with Obesity and Heart Failure Irrespective of Their Baseline Ejection Fraction: An Efficacy and Safety Meta-analysis of Randomized Controlled Trials.

Saved in:
Bibliographic Details
Title: Semaglutide in Patients with Obesity and Heart Failure Irrespective of Their Baseline Ejection Fraction: An Efficacy and Safety Meta-analysis of Randomized Controlled Trials.
Authors: Otmani Z; From the Faculty of Medicine, Mouloud Mammeri University, Tizi Ouzou, Algeria., Elsayed HA; Faculty of Medicine, Zagazig University, Zagazig, Egypt., Yassin MNA; Faculty of Medicine, Cairo University, Cairo, Egypt., Saihi MJ; Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria., Aldemerdash MA; Faculty of Medicine, Sohag University, Sohag, Egypt., Alzawahreh A; Faculty of Medicine, The Hashemite University, Zarqa, Jordan., Hassan A; Faculty of Medicine, School of Medicine, University of California, Irvine, CA., Alahmed FB; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Gonnah AR; Department of Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom., Abdelaziz A; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.; Department of Research, Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA.
Source: Cardiology in review [Cardiol Rev] 2025 May 01. Date of Electronic Publication: 2025 May 01.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9304686 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-4683 (Electronic) Linking ISSN: 10615377 NLM ISO Abbreviation: Cardiol Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-4683
DOI:10.1097/CRD.0000000000000925